Quantinno Capital Management’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.35M Buy
248,285
+233,444
+1,573% +$2.59M ﹤0.01% 2057
2026
Q2
$357K Buy
14,841
+369
+3% +$11.2K ﹤0.01% 3142
2026
Q1
$440K Buy
14,472
+2,083
+17% +$55.5K ﹤0.01% 2803
2025
Q4
$358K Buy
+12,389
New +$162K ﹤0.01% 2715

Other funds holding CAPR

Quantinno Capital Management's CAPR Position: Q3 2026 in Review

Quantinno Capital Management increased its Capricor Therapeutics (CAPR) stake by 1,573% in Q3 2026, buying an estimated $2.59M and bringing the position to 248,285 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2057.

Quantinno Capital Management first reported a position in CAPR in Q4 2025 and has held it in 4 quarters since. 158 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • Quantinno Capital Management held 248,285 shares of Capricor Therapeutics worth $2.35M as of Q3 2026.
  • Quantinno Capital Management bought 233,444 Capricor Therapeutics shares in Q3 2026, an estimated $2.59M.
  • Capricor Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2057 holding.
  • Quantinno Capital Management first reported a position in Capricor Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 158 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.